EUREKA PHARMA
The computed 12-month bankruptcy probability of EUREKA PHARMA is 0.5% (low). The company has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 20 yrs |
| Locations | 1 |
| Publications | 3 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | verkort | 30-06-2025 | 2025-00218718 |
| 31-12-2023 | verkort | 01-07-2024 | 2024-00203241 |
| 31-12-2022 | verkort | 25-08-2023 | 2023-00406224 |
| 31-12-2021 | verkort | 23-07-2022 | 2022-20248466 |
| 31-12-2020 | verkort | 12-07-2021 | 2021-35400374 |
| 31-12-2019 | verkort | 07-07-2020 | 2020-27700460 |
| 31-12-2018 | verkort | 17-06-2019 | 2019-20000013 |
| 31-12-2017 | verkort | 07-06-2018 | 2018-16700550 |
| 31-12-2016 | verkort | 13-06-2017 | 2017-17300286 |
| 31-12-2015 | verkort | 09-06-2016 | 2016-16500400 |
Historic, not recently confirmed (2)
-
Not recently confirmedlast confirmed in an act from 2014
-
Not recently confirmedlast confirmed in an act from 2014
Former directors (2)
-
Former- → 02-02-2014
-
Former- → 02-02-2014
| NACE primary | Wholesale trade(46460) |
| Legal form | Private limited company(610) |
| Incorporation | 14-11-2005 |
| Status | Active |
| Postal code | 8520 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34023C0176/00Z000 | Flanders | 6,529 m² | 1 · 4,271 m² | 12.3 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-01-2026 Capital increase of €50,000 to €50,000
- €0 → €50.000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 50000.0,
"currency": "EUR",
"after_eur": 50000.0,
"delta_eur": 50000.0,
"before_eur": 0.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2020-01-01",
"evidence_quote": "stelt de vergadering vast dat het werkelijk gestort kapitaal van de vennootschap, hetzij vijftigduizend euro (50.000,00 EUR) ... per 1 januari 2020 van rechtswege omgezet werden in een statutair onbeschikbare eigen vermogensrekening",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0877.239.492",
"name_full": "EUREKA PHARMA",
"legal_form": "BVBA"
}
}17-10-2016 Registered office moved from Waregem to Kuurme
- Kalkhoevestraat 1, 8790 Waregem → Harelbeeksestraat 81, 8520 Kuurme
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Kuurme",
"region": null,
"street": "Harelbeeksestraat",
"country": "BE",
"postcode": "8520",
"box_number": null,
"street_number": "81"
},
"old_address": {
"city": "Waregem",
"region": null,
"street": "Kalkhoevestraat",
"country": "BE",
"postcode": "8790",
"box_number": null,
"street_number": "1"
},
"effective_date": "2016-10-01",
"evidence_quote": "De zaakvoerders beslissen, overeenkomstig artikel 2 van de statuten, de zetel van de vennootschap per 01 oktober 2016 over te brengen naar : Harelbeeksestraat 81 8520 Kuurme"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0877.239.492",
"name_full": "EUREKA PHARMA",
"legal_form": "BVBA"
}
}06-03-2014 2 directors appointed, 2 resigning
- Wendy Lefebvre, Zaakvoerder
- Remko Smaak, Zaakvoerder
- Wendy Lefebvre, Zaakvoerder
- Remko Smaak, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Wendy Lefebvre",
"address": null,
"birth_date": null
},
"effective_date": "2014-02-02",
"evidence_quote": "De bijzondere algemene vergadering dd 02 februari 2014 neemt nota van het ontslag van de hierna vermelde personen als de zaakvoerders van de vennootschap ingaand op heden 02 februari 2014: de heer Wendy Lefebvre, wonende te 8511 Aalbeke (Kortrijk), Daalberg 15"
},
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Remko Smaak",
"address": null,
"birth_date": null
},
"effective_date": "2014-02-02",
"evidence_quote": "De bijzondere algemene vergadering dd 02 februari 2014 neemt nota van het ontslag van de hierna vermelde personen als de zaakvoerders van de vennootschap ingaand op heden 02 februari 2014: de heer Remko Smaak, wonende te 8710 Wielsbeke, Veen 11,"
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Wendy Lefebvre",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0544988857",
"name": "Lebo Consult GCV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2014-02-02",
"evidence_quote": "Wordt benoemd tot zaakvoerder, ingaand op 02 februari 2014 voor onbepaalde duur: - De Gewone Commanditaire Vennootschap Lebo Consult, Daalberg 15 - 8511 Aalbeke (Kortrijk) ondernemingsnummer 0544.988.857, met als vast vertegenwoordiger de heer Wendy Lefebvre wonende Daalberg 15 te 8511 Aalbeke (Kort"
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Remko Smaak",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0544991431",
"name": "Remko Smaak Consulting",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2014-02-02",
"evidence_quote": "De Gewone Commanditaire Vennootschap Remko Smaak Consulting, Veen 11 - 8710 Wielsbeke ondernemingsnummer 0544.991.431, met als vast vertegenwoordiger de heer Remko Smaak, wonende te Veen 11-8710 Wielsbeke."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0877.239.492",
"name_full": "EUREKA PHARMA",
"legal_form": "BVBA"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | EUREKA PHARMA |